)
Gasporox (GPX) investor relations material
Gasporox Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Q3 revenue fell to SEK 3.924m from SEK 9.453m and operating loss was SEK 4.116m; 9M revenue rose to SEK 21.499m and operating loss narrowed to SEK 6.933m.
Earlier strategic investments are beginning to deliver: the portfolio now includes complete LineArch and LineArch Plus machines, alongside expansion into food packaging inspection and tablet analysis.
Management entered Q4 with confidence and expects several active projects to reach milestones in 2027.
Financial highlights
Q3 net sales SEK 3.924m (9.453m); 9M net sales SEK 21.499m (20.281m).
Q3 operating loss SEK 4.116m, versus SEK 0.060m operating profit; 9M operating loss narrowed to SEK 6.933m from SEK 7.485m.
Q3 net loss SEK 4.579m (0.305m); 9M net loss SEK 8.330m (8.710m).
Q3 EBITDA was negative SEK 2.424m versus positive SEK 1.689m; 9M EBITDA was negative SEK 1.871m versus negative SEK 2.715m.
Q3 cash flow was negative SEK 1.960m; 9M cash flow was positive SEK 0.853m versus SEK 3.677m.
Outlook and guidance
Management expects a positive Q4 close to 2026 and expressed confidence entering the quarter despite Q3 weakness.
Several active projects are expected to reach important milestones in 2027; the CE-marked SpectraPore instrument is being prepared for launch in 2026/2027.
Long-term target: solutions installed on 10–20% of newly installed production lines; goal is positive cash flow without additional capital, subject to market conditions and expansion decisions.
- Laser-based inspection expands from pharma to food and tablets, driving growth and regulatory adoption.GPX
Investing in Life Science 2026 - Q2 2026 sales rose 28% year-over-year, with narrowed losses and strong pharma-driven growth.GPX
Q2 2026 - Revenue doubled and EBITDA turned positive in Q1 2026, driven by pharma and food growth.GPX
Q1 2026 - Record Q4 sales and new product launches set the stage for growth in 2026.GPX
Q4 2025 - Q3 2025 delivered 22% revenue growth and positive EBIT, with strong momentum in pharma and food.GPX
Q3 2025 - Q2 revenue fell 29% year-over-year, but a strong order backlog supports a positive H2 outlook.GPX
Q2 2025 - Q3 revenue up 14% year-over-year, with positive EBITDA and strengthened equity base.GPX
Q3 2024 - Record sales, positive cash flow, and new grants highlight strong growth and innovation.GPX
Q2 2024 - Sales declined but financing and R&D investments support future growth in quality control markets.GPX
Q1 2025
Next Gasporox earnings date
Next Gasporox earnings date
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
)
)